Just in case you needed an example of how powerful the Vaccine Put is, check out today's (September 14) action in the U.S. stocks. On positive "indications" about a possible coronavirus treatment, Incyte (INCY) was up 5.55% as of 3 p.m. New York time. On positive news about vaccine trials, Pfizer (PFE) was ahead 2.92% […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
